ConvaTec Group PLC (OTCMKTS:CNVVY – Get Free Report) was the recipient of a significant drop in short interest during the month of April. As of April 30th, there was short interest totaling 455 shares, a drop of 83.8% from the April 15th total of 2,801 shares. Based on an average daily volume of 31,619 shares, the days-to-cover ratio is currently 0.0 days.
Analysts Set New Price Targets
Separately, Sanford C. Bernstein raised ConvaTec Group to a “strong-buy” rating in a report on Wednesday, January 28th. Two equities research analysts have rated the stock with a Strong Buy rating, Based on data from MarketBeat.com, the company presently has an average rating of “Strong Buy”.
Get Our Latest Stock Analysis on ConvaTec Group
ConvaTec Group Trading Down 1.5%
ConvaTec Group Company Profile
ConvaTec Group is a global medical products and technologies company focused on developing therapies and technologies for the management of chronic health conditions. The company’s portfolio spans four core business areas—Advanced Wound Care, Ostomy Care, Continence & Critical Care, and Infusion Devices—which are designed to improve patient outcomes and enhance quality of life for people living with long-term health challenges. ConvaTec’s product range includes proprietary wound dressings, ostomy and continence management systems, and safety-engineered infusion sets.
Headquartered in Reading, United Kingdom, ConvaTec serves customers in over 100 countries through a network of manufacturing, distribution, and customer support operations.
Read More
- Five stocks we like better than ConvaTec Group
- Before the Moon Base Gets Built, These 4 Companies Win
- Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases
- 3 Stocks That Win If Inflation Surprises to the Downside
- MercadoLibre Boldly Invests in Growth: Discount Deepens
Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.
